Executive cognitive impairment detected by simple bedside testing is associated with poor glycaemic control in type 2 diabetes
Journal Article
2007
Permanent link to this Item
Authors
Journal Title
South African Medical Journal
Link to Journal
Journal ISSN
Volume Title
Publisher
Publisher
University of Cape Town
Department
Faculty
License
Series
Abstract
Aims. Cognitive impairment in people with type 2 diabetes is a barrier to successful disease management. We sought to determine whether impaired executive function as detected by a battery of simple bedside cognitive tests of executive function was associated with inadequate glycaemic control.
Methods. People with type 2 diabetes attending a tertiary referral diabetic clinic who consented to participate in the study underwent a brief battery of cognitive testing (the Bedside Executive Screening Test) designed to detect executive function impairment. Glycaemic control was determined using blood glycated haemoglobin levels (HBA1c). Inadequate glycaemic control was defined as HBA1c ≥7%. Results. Executive function impairment was detected in 51 (52%) of the 98 study participants. The presence of executive function impairment was significantly associated with poor glycaemic control (HBA1c ≥7%) (odds ratio 4.9, 95% confidence interval 1.3 - 18.8, p=0.019). There were no significant differences between patients with and without executive function impairment with regard to age, target organ damage, patient reported adherence, and hypoglycaemic therapy. Patients with a lower level of education were more likely to demonstrate executive impairment when glycaemic control was poor (p=0.013). Conclusions. Executive function impairment is common in a population of people with difficult-to-manage type 2 diabetes. The presence of executive impairment is significantly associated with poor glycaemic control.
Description
Reference:
de Wet, H., Levitt, N., & Tipping, B. (2008). Executive cognitive impairment detected by simple bedside testing is associated with poor glycaemic control in type 2 diabetes. South African medical journal, 97(11), 1074-1076.